PROCEPT BioRobotics Corp (PRCT) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for PROCEPT BioRobotics Corp (PRCT): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 47/100 — a percentile rank of PROCEPT BioRobotics Corp’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.
| Market cap | $1.0B |
| P / S | 3.1× |
| EV / EBITDA | -8.1× |
| Gross margin | 64.2% |
| Operating margin | -33.9% |
| Net margin | -32.5% |
| Return on equity | -32.3% |
| ROIC | -69.9% |
| Revenue growth | 22.7% |
| Debt / equity | 0.1× |
| Dividend yield | 0.0% |
Is PROCEPT BioRobotics Corp overvalued? P/S looks undervalued vs its 5-year range; P/B looks undervalued vs its 5-year range.
Independent of the events above — derived from PROCEPT BioRobotics Corp’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact